Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 6/20 | 0.43 |
| ▸ | SRC | P12931 | 4/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24311359 | 0.89 | HTT (0.49) | HTTMITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL22510633 | 0.70 | ALDH1A1 (0.63) | HTTALDH1A1FGFR1SRC | |
| SCHEMBL13656880 | 0.69 | FGFR1 (0.53) | HTTALDH1A1FGFR1SRC | |
| SCHEMBL17691571 | 0.68 | HTT (0.56) | HTTALDH1A1FGFR1SRCCYP17A1 | |
| SCHEMBL17691570 | 0.67 | FGFR1 (0.65) | HTTALDH1A1FGFR1SRC | |
| SCHEMBL22883855 | 0.65 | CYP2A6 (0.48) | GAA | |
| SCHEMBL20057789 | 0.65 | ALDH1A1 (0.49) | HTTMITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL218508 | 0.64 | TRPA1 (0.52) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL30834716 | 0.64 | TRPA1 (0.52) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL2403531 | 0.64 | NUDT1 (0.43) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337523-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337523-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OCIAD1, OCIAD2 | HTT 3577/4885MITF 3029/4885ALDH1A1 545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.